NeuBase Therapeutics (NBSE) Institutional Ownership → How Biden has already won 2024 (From Porter & Company) (Ad) Free NBSE Stock Alerts $0.38 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Institutional Ownership Changes (13F Filings) for NeuBase Therapeutics (NASDAQ:NBSE)CurrentInstitutional OwnershipPercentage12.37%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$4.51M Get NBSE Insider Trade Alerts Want to know when executives and insiders are buying or selling NeuBase Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NBSE Institutional Buying and Selling by Quarter Ad Wealthpin ProThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. NeuBase Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2023 Prelude Capital Management LLC15,550$29K0.0%-95.0%0.920% 8/10/2023Jacob Asset Management of New York LLC15,655$29K0.0%-95.0%0.926% 8/1/2023 Carnegie Mellon University46,970$88K0.1%-95.0%2.779% 7/28/2023Decheng Capital Management III Cayman LLC50,000$92K0.0%-95.0%2.959% 2/9/2023 CM Management LLC350,000$67K0.1%-22.2%1.060% 11/14/2022 Worth Venture Partners LLC212,035$84K0.1%-17.4%0.657% Get the Latest News and Ratings for NBSE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuBase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/4/2022 CM Management LLC450,000$178K0.2%+21.6%1.395% 8/8/2022 CM Management LLC370,000$389K0.4%+13.8%1.147% 7/29/2022 Perkins Capital Management Inc.81,500$86K0.1%+22.6%0.253% 5/12/2022 AIGH Capital Management LLC1,027,585$1.93M0.5%+2.7%3.136% 5/10/2022Decheng Capital Management III Cayman LLC1,000,000$1.88M0.6%N/A3.052% 5/9/2022 CM Management LLC325,000$611K0.5%+116.7%0.992% 5/9/2022Wealthsource Partners LLC23,850$45K0.0%N/A0.073% 5/4/2022 Waldron Private Wealth LLC79,620$149K0.0%+296.4%0.243% 4/20/2022 Perkins Capital Management Inc.66,500$125K0.1%+121.7%0.203% 2/14/2022 Fifth Lane Capital LP20,000$56K0.0%N/A0.061% 2/10/2022 Perkins Capital Management Inc.30,000$84K0.1%+42.9%0.092% 2/10/2022 AIGH Capital Management LLC1,000,285$2.81M0.9%N/A3.057% 2/9/2022Jacob Asset Management of New York LLC426,424$1.20M0.5%+4.6%1.303% 2/2/2022 CM Management LLC150,000$422K0.3%+100.0%0.458% 11/16/2021 Two Sigma Advisers LP178,821$646K0.0%-12.4%0.547% 11/15/2021 Marshall Wace LLP50,310$182K0.0%-63.1%0.154% 11/15/2021 Tocqueville Asset Management L.P.74,000$267K0.0%+156.9%0.226% 11/15/2021 GSA Capital Partners LLP351,178$1.27M0.1%+1.5%1.073% 11/12/2021 Renaissance Technologies LLC391,193$1.41M0.0%-7.9%1.196% 11/12/2021 Stonepine Capital Management LLC109,742$396K0.2%+253.2%0.335% 11/12/2021Jacob Asset Management of New York LLC407,500$1.47M0.5%+17.9%1.246% 11/10/2021 Goldman Sachs Group Inc.104,796$378K0.0%-4.5%0.320% 11/9/2021 BlackRock Inc.81,716$295K0.0%-6.0%0.250% 11/8/2021 CM Management LLC75,000$271K0.2%N/A0.229% 10/25/2021 Perkins Capital Management Inc.21,000$76K0.0%+41.9%0.064% 8/25/2021 Marshall Wace LLP136,421$653K0.0%N/A0.417% 8/17/2021 Walleye Capital LLC17,212$82K0.0%N/A0.053% 8/17/2021 Millennium Management LLC174,020$834K0.0%+276.2%0.532% 8/16/2021 Point72 Asset Management L.P.1,250,000$5.99M0.0%N/A3.821% 8/16/2021 Cubist Systematic Strategies LLC6,832$33K0.0%N/A0.021% 8/16/2021Greenlight Capital Inc.2,727,027$13.06M0.8%+34.5%8.335% 8/16/2021 First Trust Advisors LP73,098$350K0.0%+36.2%0.223% 8/16/2021 Royal Bank of Canada85,955$412K0.0%+664.5%0.263% 8/16/2021 Charles Schwab Investment Management Inc.15,720$76K0.0%-61.8%0.048% The #1 Crypto That You Don’t Own… Yet (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details…8/16/2021 State Street Corp23,813$114K0.0%-90.8%0.073% 8/16/2021Tibra Equities Europe Ltd66,400$318K0.1%N/A0.203% 8/16/2021 Goldman Sachs Group Inc.109,685$525K0.0%+5.2%0.335% 8/16/2021 Marshall Wace LLP136,421$653K0.0%N/A0.417% 8/16/2021 Tocqueville Asset Management L.P.28,800$138K0.0%-38.1%0.088% 8/13/2021 Renaissance Technologies LLC424,851$2.04M0.0%+116.9%1.299% 8/13/2021 Northern Trust Corp54,926$263K0.0%-69.9%0.168% 8/13/2021 Geode Capital Management LLC233,856$1.12M0.0%-25.9%0.715% 8/13/2021 Vanguard Group Inc.1,297,848$6.22M0.0%+35.4%3.967% 8/12/2021 Trexquant Investment LP19,230$92K0.0%N/A0.059% 8/12/2021Ergoteles LLC76,652$367K0.0%N/A0.234% 8/11/2021 Bank of New York Mellon Corp87,210$418K0.0%-29.0%0.267% 8/11/2021 Deutsche Bank AG100,000$479K0.0%+754.7%0.306% 8/9/2021 Heritage Wealth Advisors9,000$63K0.0%+80.0%0.028% 8/6/2021 Waldron Private Wealth LLC20,088$96K0.0%N/A0.061% 8/5/2021 GSA Capital Partners LLP346,151$1.66M0.2%+465.9%1.058% 7/27/2021 Heritage Wealth Advisors9,000$63K0.0%+80.0%0.028% 5/18/2021 Millennium Management LLC46,253$342K0.0%+134.8%0.200% 5/18/2021 D. E. Shaw & Co. Inc.96,239$711K0.0%+133.8%0.415% 5/18/2021 Glenview Capital Management LLC100,000$739K0.0%N/A0.431% 5/17/2021 Royal Bank of Canada11,244$83K0.0%+121.1%0.049% 5/17/2021 Polar Asset Management Partners Inc.634,618$4.69M0.0%N/A2.738% 5/17/2021 Nuveen Asset Management LLC93,911$694K0.0%-18.4%0.405% 5/17/2021 Sphera Funds Management LTD.31,900$236K0.0%N/A0.138% 5/17/2021 Goldman Sachs Group Inc.104,235$770K0.0%+16.6%0.450% 5/13/2021 Renaissance Technologies LLC195,878$1.45M0.0%-53.6%0.845% 5/12/2021 Northern Trust Corp182,286$1.35M0.0%-8.1%0.786% 5/12/2021 Geode Capital Management LLC315,525$2.33M0.0%+24.3%1.361% 5/12/2021 MYDA Advisors LLC45,000$333K0.1%N/A0.194% 5/12/2021 JPMorgan Chase & Co.51,222$379K0.0%+5.4%0.221% 5/10/2021 GSA Capital Partners LLP61,163$452K0.1%-49.6%0.264% 5/10/2021 Oppenheimer & Co. Inc.10,750$79K0.0%N/A0.046% 4/29/2021 Opal Wealth Advisors LLC20,000$148K0.2%N/A0.086% 4/27/2021 Heritage Wealth Advisors5,000$37K0.0%-44.4%0.022% 3/26/2021Susquehanna International Group LLP39,776$278K0.0%N/A0.172% 2/19/2021 JPMorgan Chase & Co.48,581$340K0.0%+370.4%0.210% 2/16/2021 Nuveen Asset Management LLC115,097$805K0.0%-22.7%0.497% 2/16/2021 Prelude Capital Management LLC311,000$2.17M0.1%N/A1.342% 2/11/2021 Trexquant Investment LP15,479$108K0.0%N/A0.067% 2/11/2021 Northern Trust Corp198,246$1.39M0.0%+1.8%0.855% 2/10/2021 Rhumbline Advisers16,595$116K0.0%+8.0%0.072% 2/10/2021 Renaissance Technologies LLC422,378$2.95M0.0%-24.1%1.822% 2/10/2021 Group One Trading L.P.3,860$27K0.0%N/A0.017% 2/9/2021 Wells Fargo & Company MN32,827$230K0.0%+8.9%0.142% 2/9/2021 Bank of New York Mellon Corp124,444$870K0.0%+36.1%0.537% 2/8/2021 New York State Common Retirement Fund9,200$64K0.0%-41.8%0.040% 2/5/2021 BlackRock Inc.929,233$6.50M0.0%+2.5%4.009% 2/4/2021 GSA Capital Partners LLP121,389$849K0.1%+25.7%0.524% 2/2/2021 First Trust Advisors LP49,228$344K0.0%-4.3%0.212% 2/1/2021 Heritage Wealth Advisors9,000$63K0.0%-18.2%0.039% Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it.11/16/2020Greenlight Capital Inc.2,027,027$15.39M1.3%+6.5%8.767% 11/13/2020 Morgan Stanley11,672$89K0.0%-22.3%0.050% 11/13/2020 Oak Grove Capital LLC19,975$152K0.1%-28.6%0.086% 11/13/2020 Charles Schwab Investment Management Inc.41,158$313K0.0%-5.3%0.178% 11/12/2020 JPMorgan Chase & Co.10,328$78K0.0%-19.9%0.045% 11/12/2020 Arrowstreet Capital Limited Partnership54,700$415K0.0%N/A0.237% 11/10/2020 State Street Corp277,645$2.11M0.0%+11.6%1.201% 11/6/2020 BlackRock Inc.906,303$6.88M0.0%-2.8%3.920% 11/6/2020 GSA Capital Partners LLP96,586$733K0.1%N/A0.418% 11/5/2020 First Trust Advisors LP51,453$391K0.0%N/A0.223% (Data available from 1/1/2016 forward) NBSE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NBSE shares? During the previous two years, the following institutional investors and hedge funds held shares of NeuBase Therapeutics shares: Decheng Capital Management III Cayman LLC ($92K), Carnegie Mellon University ($88K), Perkins Capital Management Inc. ($86K), Worth Venture Partners LLC ($84K), CM Management LLC ($67K), and Prelude Capital Management LLC ($29K), and Jacob Asset Management of New York LLC ($29K).Learn more on NBSE's institutional investors. What percentage of NeuBase Therapeutics stock is owned by institutional investors? 12.37% of NeuBase Therapeutics stock is owned by institutional investors. Learn more on NBSE's institutional investor holdings. Which institutional investors have been buying NeuBase Therapeutics stock? The following institutional investors have purchased NeuBase Therapeutics stock in the last 24 months: CM Management LLC ($125K), and Perkins Capital Management Inc. ($15K). How much institutional buying is happening at NeuBase Therapeutics? Institutional investors have bought a total of 140,000 shares in the last 24 months. This purchase volume represents approximately $1.89M in transactions. Which NeuBase Therapeutics major shareholders have been selling company stock? The following institutional investors have sold NeuBase Therapeutics stock in the last 24 months: Decheng Capital Management III Cayman LLC ($950K), Carnegie Mellon University ($892.44K), Jacob Asset Management of New York LLC ($297.45K), Prelude Capital Management LLC ($295.45K), CM Management LLC ($100K), and Worth Venture Partners LLC ($44.52K). How much institutional selling is happening at NeuBase Therapeutics? Institutional investors have sold a total of 2,579,855 shares in the last 24 months. This volume of shares sold represents approximately $5.24M in transactions. Related Companies: ALLR Institutional Ownership DRMA Institutional Ownership PRFX Institutional Ownership QLGN Institutional Ownership NLSP Institutional Ownership ATNF Institutional Ownership GLMD Institutional Ownership VRPX Institutional Ownership INM Institutional Ownership CMND Institutional Ownership This page (NASDAQ:NBSE) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceLEAKED: Jeff Bezos' $330 Million GambleBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuBase Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.